UK AstraZeneca recipients die of clots; regulator: Benefits outweigh risks

The Netherlands suspends use of AstraZeneca vaccine for under-60s

The Netherlands suspends use of AstraZeneca vaccine for under-60s

A more detailed look at the MHRA's findings shows that of the 30 cases, 22 related to cerebral venous sinus thrombosis, which stops blood draining from the brain properly, and eight were connected with other thrombosis events with low platelets.

The Netherlands on Friday became the latest in a line of European countries to halt vaccinations with the AstraZeneca jab for people under the age of 60 amid fears of links to rare blood clots.

The head of the European Medicines Agency (EMA) has said that there is "no evidence" to support restricting the use of the AstraZeneca vaccine in any population. Scientists have said that case counts would inevitably rise among vaccinated people as doctors began looking more closely for the condition.

In a statement on Friday, the Australian Technical Advisory Group on Immunization said, "There is not a higher overall rate of relatively common types of blood clots. reported after COVID-19 vaccination".

"The risk of having this specific type of blood clot is very small", the agency noted.

America's leading expert on infectious diseases, Dr Anthony Fauci, has said the United States may not need the AstraZeneca vaccine against coronavirus even if the country's Food and Drug Administration (FDA) authorises its use. It has said a causal link between unusual blood clots in people who have had the vaccine is "not proven, but is possible", and that the benefits of the vaccine outweigh the risks of side effects.

California: Several dead after shooting at office building
Four people were killed and another is in critical condition after a shooting in Orange, California . Orange, a city of about 140,000 residents, is located about 48km southeast of downtown Los Angeles .

Australia will continue its inoculation programme with AstraZeneca PLC, health officials said on Saturday, after a blood clotting case raised concern about the safety of the vaccine.

"Receiving the vaccine is by far the safest choice in terms of minimizing individual risk of serious illness or death", he said.

"That's still up in the air", said Fauci when asked whether the US will use the AstraZeneca vaccine doses. Several nations, including Canada, France, Germany and Spain, limited its use after similar reports.

Britain's medicines regulator said that it had received reports of no such clotting cases in people who had received the Pfizer-BioNTech vaccine.

Overall, about one in every million people have this clot every year anyway, the GP explained.

On Thursday, Germany's immunisation commission, the STIKO, recommended that anyone younger than 60 who received an initial vaccination with AstraZeneca be given either Pfizer-BioNTech or Moderna shots as their second vaccine doses.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.